Open access peer-reviewed chapter

Advances in MicroRNAs and Alzheimer’s Disease Research

By Francesca Ruberti, Silvia Pezzola and Christian Barbato

Submitted: October 21st 2010Reviewed: April 4th 2011Published: September 12th 2011

DOI: 10.5772/17635

Downloaded: 2559

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike-3.0 License, which permits use, distribution and reproduction for non-commercial purposes, provided the original is properly cited and derivative works building on this content are distributed under the same license.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Francesca Ruberti, Silvia Pezzola and Christian Barbato (September 12th 2011). Advances in MicroRNAs and Alzheimer’s Disease Research, Alzheimer's Disease Pathogenesis - Core Concepts, Shifting Paradigms and Therapeutic Targets, Suzanne De La Monte, IntechOpen, DOI: 10.5772/17635. Available from:

chapter statistics

2559total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Role of Mitochondria in Alzheimer ́s Disease

By Genaro Genaro Gabriel Ortiz, Fermín Pacheco-Moisés, José de Jesús García-Trejo, Roció E. González-Castañeda, Miguel A. Macías-Islas, José A. Cruz-Ramos, Irma E. Velázquez-Brizuela, Elva D. Árias Merino and Alfredo Célis de la Rosa

Related Book

First chapter

Risk Factors for Disease Progression in Alzheimer's Disease

By Schmidt C, Wolff M, Shalash A and Zerr I

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us